Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Capturing the molecular and biological diversity of high-grade astrocytoma in genetically engineered mouse models.

Chow LM, Baker SJ.

Oncotarget. 2012 Jan;3(1):67-77. Review.

PMID:
22287481
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Genetically engineered mouse models of astrocytoma: GEMs in the rough?

Reilly KM, Jacks T.

Semin Cancer Biol. 2001 Jun;11(3):177-91. Review.

PMID:
11407943
[PubMed - indexed for MEDLINE]
3.

Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK.

Genes Dev. 2007 Nov 1;21(21):2683-710. Review.

PMID:
17974913
[PubMed - indexed for MEDLINE]
Free Article
4.

Emerging role of new transgenic mouse models in glioma research.

Sonabend AM, Ulasov IV, Lesniak MS.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S7-13. doi: 10.1586/14737140.7.12s.S7. Review.

PMID:
18076321
[PubMed - indexed for MEDLINE]
5.

High-grade glioma mouse models and their applicability for preclinical testing.

de Vries NA, Beijnen JH, van Tellingen O.

Cancer Treat Rev. 2009 Dec;35(8):714-23. doi: 10.1016/j.ctrv.2009.08.011. Epub 2009 Sep 19. Review.

PMID:
19767151
[PubMed - indexed for MEDLINE]
6.

Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation.

Xiao A, Yin C, Yang C, Di Cristofano A, Pandolfi PP, Van Dyke T.

Cancer Res. 2005 Jun 15;65(12):5172-80.

PMID:
15958561
[PubMed - indexed for MEDLINE]
Free Article
7.

Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.

Llaguno SA, Chen J, Kwon CH, Parada LF.

Cold Spring Harb Symp Quant Biol. 2008;73:421-6. doi: 10.1101/sqb.2008.73.005. Epub 2008 Nov 6. Review.

PMID:
19022744
[PubMed - indexed for MEDLINE]
8.

Astrocytic tumors.

Riemenschneider MJ, Reifenberger G.

Recent Results Cancer Res. 2009;171:3-24. doi: 10.1007/978-3-540-31206-2_1. Review.

PMID:
19322535
[PubMed - indexed for MEDLINE]
9.

Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model.

Shannon P, Sabha N, Lau N, Kamnasaran D, Gutmann DH, Guha A.

Am J Pathol. 2005 Sep;167(3):859-67.

PMID:
16127163
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk.

Reilly KM.

Brain Pathol. 2009 Jan;19(1):121-31. doi: 10.1111/j.1750-3639.2008.00236.x.

PMID:
19076777
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Mouse astrocytoma models: embryonic stem cell mediated transgenesis.

Ding H, Guha A.

J Neurooncol. 2001 Jul;53(3):289-96.

PMID:
11718261
[PubMed - indexed for MEDLINE]
12.

Diagnosis and treatment of high-grade astrocytoma.

Sathornsumetee S, Rich JN, Reardon DA.

Neurol Clin. 2007 Nov;25(4):1111-39, x. Review.

PMID:
17964028
[PubMed - indexed for MEDLINE]
13.

Advances in the biology of astrocytomas.

Guha A, Mukherjee J.

Curr Opin Neurol. 2004 Dec;17(6):655-62. Review.

PMID:
15542973
[PubMed - indexed for MEDLINE]
14.

Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.

Ishii N, Sawamura Y, Tada M, Daub DM, Janzer RC, Meagher-Villemure M, de Tribolet N, Van Meir EG.

Int J Cancer. 1998 Jun 10;76(6):797-800.

PMID:
9626343
[PubMed - indexed for MEDLINE]
15.

Pathology of low- and intermediate-grade gliomas.

Fuller CE, Perry A.

Semin Radiat Oncol. 2001 Apr;11(2):95-102.

PMID:
11285547
[PubMed - indexed for MEDLINE]
16.

The molecular biology of WHO grade I astrocytomas.

Marko NF, Weil RJ.

Neuro Oncol. 2012 Dec;14(12):1424-31. doi: 10.1093/neuonc/nos257. Epub 2012 Oct 22. Review.

PMID:
23090984
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A tiger behind many doors: multiple genetic pathways to malignant glioma.

Louis DN, Gusella JF.

Trends Genet. 1995 Oct;11(10):412-5. Review.

PMID:
7482768
[PubMed - indexed for MEDLINE]
18.

Pathology and molecular genetics of astrocytic gliomas.

Reifenberger G, Collins VP.

J Mol Med (Berl). 2004 Oct;82(10):656-70. Review.

PMID:
15316624
[PubMed - indexed for MEDLINE]
19.

Alterations of the p53 and pRB pathways in human astrocytoma.

Rutka JT, Akiyama Y, Lee SP, Ivanchuk S, Tsugu A, Hamel PA.

Brain Tumor Pathol. 2000;17(2):65-70. Review.

PMID:
11210173
[PubMed - indexed for MEDLINE]
20.

Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12.

Amlin-Van Schaick JC, Kim S, DiFabio C, Lee MH, Broman KW, Reilly KM.

Neuro Oncol. 2012 Feb;14(2):160-74. doi: 10.1093/neuonc/nor206. Epub 2012 Jan 10.

PMID:
22234937
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk